Discuss your experiences with the benefits, risks, and side effects of immunotherapy treatment for breast cancer.
Posted on: Sep 1, 2021 12:54PM
Genentech Withdraws Breast Cancer Indication From Tecentriq
August 28, 2021
On Aug. 27, 2021, Genentech announced it is voluntarily withdrawing the breast cancer indication from the immunotherapy medicine Tecentriq in the United States. Read more...